John Levine
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| MAGIC Ruxolitinib for aGVHD (NCT06936566) | John Levine | 2025-05-14 |
| Pediatric GVHD Low Risk Steroid Taper Trial (NCT05090384) | John Levine | 2022-10-20 |
| Itacitinib for Low Risk GVHD (NCT03846479) | John Levine | 2019-03-25 |
| A Proof of Concept Pilot Trial of Alpha-1-Antitrypsin for Pre-Emption Of Steroid-Refractory Acute GVHD (NCT03459040) | John Levine | 2018-08-17 |
Track John Levine automatically
Every clearance here is in the API, with alerts when new ones post.